Evaxion A/S - American Depositary Share (EVAX) closed at $3.71 on October 21, 2026, down 8.4% from the previous close, on volume of 319,128 shares (30-day average 74,523).
Data as of October 21, 2026.
TipRanks (Tue, 20-Oct 4:30 PM ET)
EVAX jumps as EVX-01 melanoma vaccine shows sustained responses at three-year follow-up
Market Chameleon (Tue, 20-Oct 7:03 AM ET)
TipRanks (Mon, 19-Oct 12:50 PM ET)
Evaxion Posts Durable Three-Year Responses in Phase 2 Trial of Personalized Cancer Vaccine EVX-01
TipRanks (Mon, 19-Oct 6:28 AM ET)
Globe Newswire (Mon, 19-Oct 3:00 AM ET)
Globe Newswire (Fri, 2-Oct 9:00 AM ET)
Evaxion applies its AI-Immunology platform in autoimmune diseases
Globe Newswire (Mon, 14-Sep 8:00 AM ET)
Evaxion’s R&D Milestones and Extended Cash Runway Highlight 2026 Outlook
Market Chameleon (Thu, 20-Aug 7:06 AM ET)
Evaxion announces business update and second quarter 2026 financial results
Globe Newswire (Thu, 20-Aug 7:30 AM ET)
Globe Newswire (Mon, 17-Aug 8:00 AM ET)
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
Evaxion A/S - American Depositary Share trades on the NASDAQ stock market under the symbol EVAX.
As of October 21, 2026, EVAX stock price declined to $3.71 with 319,128 million shares trading.
EVAX has a beta of 1.55, meaning it tends to be more sensitive to market movements. EVAX has a correlation of 0.06 to the broad based SPY ETF.
EVAX has a market cap of $33.47 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, EVAX traded as high as $340.25 and as low as $1.20.
EVAX has underperformed the market in the last year with a return of -47.7%, while SPY returned +16.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in EVAX shares. However, EVAX has outperformed the market in the last 3 month and 2 week periods, returning +26.2% and +17.4%, while SPY returned +4.4% and -0.8%, respectively. This indicates EVAX has been having a stronger performance recently.
EVAX support price is $3.84 and resistance is $4.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVAX shares will trade within this expected range on the day.